CAREFUSION CORPORATION
CFN
CFN was delisted on the 16th of March, 2015.
419 hedge funds and large institutions have $8.52B invested in CAREFUSION CORPORATION in 2014 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 103 increasing their positions, 177 reducing their positions, and 47 closing their positions.
84% more call options, than puts
Call options by funds: $24.2M | Put options by funds: $13.2M
10% more capital invested
Capital invested by funds: $7.71B → $8.52B (+$806M)
4% more first-time investments, than exits
New positions opened: 49 | Existing positions closed: 47
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
1% less funds holding
Funds holding: 422 → 419 (-3)
42% less repeat investments, than reductions
Existing positions increased: 103 | Existing positions reduced: 177
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$167M |
| 2 |
GCM
Glenview Capital Management
New York
|
+$79M |
| 3 |
JP Morgan Chase
New York
|
+$75.4M |
| 4 |
O
OrbiMed
New York
|
+$68.7M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$66.8M |
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$86.2M |
| 2 |
EC
Eminence Capital
New York
|
-$67.7M |
| 3 |
SFM
Systematic Financial Management
Teaneck,
New Jersey
|
-$65.2M |
| 4 |
Allianz Asset Management
Munich,
Germany
|
-$41.9M |
| 5 |
Charles Schwab
San Francisco,
California
|
-$35.9M |
CFN Hedge Fund Activity: Q2 2014 in Review
419 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in CAREFUSION CORPORATION (CFN) for Q2 2014, worth a combined $8.52B — up 10% from $7.71B a quarter earlier.
Buyers outnumbered sellers: 49 funds opened new CFN positions and 47 closed out — a net gain of 2 holders — while 103 added to existing stakes and 177 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $167M. The largest seller was Goldman Sachs, cutting an estimated $86.2M.
- 419 institutional investors held CAREFUSION CORPORATION (CFN) as of Q2 2014, down from 422 in Q1 2014.
- Funds reported $8.52B of CAREFUSION CORPORATION stock for Q2 2014, up 10% quarter-over-quarter.
- 49 funds opened new CAREFUSION CORPORATION positions in Q2 2014 and 47 closed out, a net change of +2 holders.
- The largest CAREFUSION CORPORATION buyer in Q2 2014 was T. Rowe Price Associates, an estimated $167M added.
- The largest CAREFUSION CORPORATION seller in Q2 2014 was Goldman Sachs, an estimated $86.2M sold.
Based on aggregated 13F filings for Q2 2014.